Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NS
551
DELISTED
NuStar Energy L.P.
NS
| $4.14M | ﹤0.01% |
69,686
+24,534
| +54% | +$1.55M |
|
552
Enbridge
ENB
$120B
| $4.07M | ﹤0.01% |
86,887
+2,550
| +3% | +$127K |
|
|
INNL
553
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $4.06M | ﹤0.01% |
276,184
-71,644
| -21% | -$794K |
|
554
Edwards Lifesciences
EW
$49.4B
| $4.05M | ﹤0.01% |
+170,730
| New | +$3.85M |
|
555
Thomson Reuters
TRI
$46.4B
| $3.8M | ﹤0.01% |
85,986
-715,547
| -89% | -$33.5M |
|
556
RBC Bearings
RBC
$17.4B
| $3.78M | ﹤0.01% |
52,620
-3,301
| -6% | -$242K |
|
557
USA Compression Partners
USAC
$3.69B
| $3.75M | ﹤0.01% |
195,902
+97,448
| +99% | +$2.09M |
|
|
RRMS
558
DELISTED
ROSE ROCK MIDSTREAM L P COM UNIT REPSTG LTD (DE)
RRMS
| $3.75M | ﹤0.01% |
80,227
+16,743
| +26% | +$833K |
|
559
Plexus
PLXS
$6.43B
| $3.71M | ﹤0.01% |
84,550
+6,469
| +8% | +$287K |
|
560
Ameriprise Financial
AMP
$47.8B
| $3.67M | ﹤0.01% |
29,348
+19,194
| +189% | +$2.45M |
|
561
Piper Sandler
PIPR
$4.99B
| $3.6M | ﹤0.01% |
329,984
-2,464
| -0.7% | -$30.7K |
|
562
Amgen
AMGN
$209B
| $3.6M | ﹤0.01% |
23,445
+11,511
| +96% | +$1.84M |
|
563
NOV
NOV
$6.84B
| $3.6M | ﹤0.01% |
74,455
-1,017,894
| -93% | -$52.3M |
|
|
LHO
564
DELISTED
LaSalle Hotel Properties
LHO
| $3.58M | ﹤0.01% |
101,059
-31
| -0% | -$1.15K |
|
565
IBM
IBM
$213B
| $3.56M | ﹤0.01% |
+22,925
| New | +$3.68M |
|
566
Parker-Hannifin
PH
$120B
| $3.51M | ﹤0.01% |
+30,153
| New | +$3.64M |
|
567
Franklin Resources
BEN
$16.8B
| $3.5M | ﹤0.01% |
71,329
+32,528
| +84% | +$1.67M |
|
568
Blackrock
BLK
$167B
| $3.48M | ﹤0.01% |
10,050
-6
| -0.1% | -$2.19K |
|
569
Walmart Inc
WMT
$909B
| $3.47M | ﹤0.01% |
146,682
+14,019
| +11% | +$357K |
|
570
Corning
GLW
$107B
| $3.42M | ﹤0.01% |
173,583
+19,699
| +13% | +$421K |
|
571
Verastem
VSTM
$528M
| $3.42M | ﹤0.01% |
37,795
+330
| +0.9% | +$34.9K |
|
572
MacroGenics
MGNX
$233M
| $3.42M | ﹤0.01% |
90,056
+904
| +1% | +$29.7K |
|
|
SMC
573
Summit Midstream
SMC
$420M
| $3.42M | ﹤0.01% |
6,896
+2,106
| +44% | +$1.04M |
|
574
Moog Inc Class A
MOG.A
$12.4B
| $3.41M | ﹤0.01% |
48,291
-1,775
| -4% | -$126K |
|
575
CrossAmerica Partners
CAPL
$834M
| $3.4M | ﹤0.01% |
120,445
+9,511
| +9% | +$303K |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.